## Abstract Bone marrow‐derived mesenchymal stem cells (MSC) are multipotent, self‐renewing, mesodermal‐origin stem cells that are sequestered in the endosteal compartment. MSC are maintained in a relative state of quiescence in vivo but in response to a variety of physiological and pathological st
Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells
✍ Scribed by Toshitaka Arikawa; Ken Omura; Ikuo Morita
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 209 KB
- Volume
- 200
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cyclooxygenase (COX)‐2 is generally known as an inducible enzyme, and it produces arachidonic acid to prostaglandin E2 (PGE2), which modulates bone metabolism. Here, we investigated the expression and role of COX isomers in human mesenchymal stem cells. Human mesenchymal stem cells constitutively expressed COX‐2 as well as COX‐1, and secretion of PGE2 was completely inhibited by NS‐398, a specific inhibitor of COX‐2. Levels of secreted PGE2 were strikingly higher in human mesenchymal stem cells than in osteoblastic cells differentiated from the mesenchymal cells. This higher production of PGE2 in mesenchymal stem cells was due to higher expression of membrane‐associated PGE synthase (mPGES) regulated by early growth response factor‐1 (Egr‐1). Treatment of human mesenchymal stem cells with NS‐398 suppressed expression of bone morphogenetic protein‐2 (BMP‐2). The suppression of BMP‐2 by NS‐398 was abrogated by an EP4 receptor agonist as well as by PGE2. Moreover, BMP‐2 expression was suppressed by an EP4 receptor antagonist. These data indicate that PGE2 produced by COX‐2 increases BMP‐2 expression via binding the EP4 receptor. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Bone morphogenetic proteins (BMP) stimulate osteoblast differentiation by signal transduction via three BMP receptors (BMPR‐IA, ‐IB, and ‐II). Several growth factors, including transforming growth factor‐β1 (TGF‐β1), fibroblast growth factor‐2 (FGF‐2) and platelet‐derived growth factor‐
## Abstract Ghrelin, a newly identified gastric peptide, is known for its potent activity in growth hormone release and appetite. Our recent study showed that ghrelin could stimulate protein kinase C‐mediated activation of nuclear factor‐κB (NF‐κB) and interleukin‐8 secretion in human colonic epith
Connexin43 (Cx43) forms gap junctions that mediate intercellular communication between osteoblasts. We have examined the effects of prostaglandin E 2 (PGE 2 ) and parathyroid hormone (PTH) on gap junctional communication in the rat osteogenic sarcoma cells UMR 106-01. Incubation with either PGE 2 o
## Abstract Overexpression of cyclooxygenase‐2 (COX‐2) and elevation of its derivative prostaglandin E~2~ (PGE~2~) are implicated in human esophageal squamous cell carcinoma. The expression of c‐Myc, an oncogenic transcription factor, is also upregulated in this malignant disease. This study sought
Insulin-like growth factor-1, IGF-1, is believed to be an important anabolic modulator of cartilage metabolism whose action is mediated by high affinity cell surface receptors and bioactivity and bioavailability regulated, in part, by IGF-1 binding proteins (IGFBPs). Prostaglandin E 2 (PGE 2 ) stimu